Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peanut Allergy Oral Immunotherapy Desensitization
NCT01601522Phase 2Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Feb 2012
- Primary completion
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes, Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of peanut protein in peanut allergy, sponsored by Hamilton Health Sciences. Started Feb 2012; status: completed.
02
Drugs
peanut protein
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT01601522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601522.